Jacob Jipp, MD
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,002 of the $2,987 with a category attached, or 67.0%. 25 manufacturers reported payments, led by Teleflex LLC at 38.2% of the total. Reporting peaked in 2021 at $1,296 and has fallen 84.0% since, to $208 in 2025.
Across 69 payments — averaging $43.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teleflex LLC$1K
- Medtronic$333
- Boston Scientific$248
- Dornier Medtech America, Inc$195
- AbbVie$144
- Myriad Genetic Laboratories, Inc.$132
- plus $794 from 19 others
What the payments were for
- Travel & lodging$92031%
- Food & beverage$2,00267%
- Education$652%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teleflex LLC | 13 | $1,141 |
| Medtronic | 5 | $333 |
| Boston Scientific | 4 | $248 |
| Dornier Medtech America, Inc | 1 | $195 |
| AbbVie | 7 | $144 |
| Myriad Genetic Laboratories, Inc. | 4 | $132 |
| Johnson & Johnson | 5 | $105 |
| Astellas Pharma US Inc | 3 | $94 |
| Pfizer | 2 | $81 |
| KARL Storz Endoscopy-america | 2 | $78 |
| Axonics, Inc. | 3 | $63 |
| Coloplast | 3 | $52 |
| Urogen Pharma, Inc. | 2 | $51 |
| Verity Pharmaceuticals Inc. | 2 | $38 |
| Conmed Corporation | 1 | $33 |
| Amgen | 2 | $27 |
| Olympus America Inc. | 1 | $26 |
| Calyxo, Inc. | 1 | $25 |
| Urovant Sciences Inc | 2 | $25 |
| Ferring Pharmaceuticals Inc. | 1 | $17 |
| Myovant Sciences Inc. | 1 | $17 |
| Cook Medical LLC | 1 | $17 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $16 |
| Endo Pharmaceuticals Inc. | 1 | $15 |
| Endo USA, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UroLift System$659
- INTERSTIM$245
- Dornier MedTech$195
- SOLYX$105
How this compares
$2,987 in reported general payments places this provider in the 60th percentile of 114 urology providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OrgovyxRelugolix | 16 | $39,767 |
| Abiraterone Acetate | 17 | $12,904 |
| MyrbetriqMirabegron | 20 | $12,576 |
| Tamsulosin Hcl | 273 | $2,694 |
| Potassium Citrate ErPotassium Citrate | 15 | $2,004 |
| Solifenacin Succinate | 44 | $1,978 |
| Trospium Chloride ErTrospium Chloride | 12 | $1,823 |
| Oxybutynin Chloride ErOxybutynin Chloride | 106 | $1,508 |
| Trospium Chloride | 25 | $1,034 |
| Finasteride | 67 | $661 |
| Cephalexin | 46 | $195 |
| Oxycodone Hcl | 42 | $105 |
| Ciprofloxacin Hcl | 29 | $101 |
| Prednisone | 34 | $95 |
| Tramadol Hcl | 37 | $58 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $94 | $12,57620 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 114 urology providers in Iowa.
Other urology in Clive
- Ryan DornbierClive$55K
- Mark KellermanClive$14K
- Trevor WildClive$10K
- Stephanie Courson PothovenClive$8K
- McCabe KennyClive$5K
- Brian GallagherClive$4K
- Vignesh PackiamIowa City$112K
- Annah VollstedtIowa City$66K
- Bradley EricksonIowa City$65K
- Michael OdonnellIowa City$62K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.